Fecal Microbiota Transplantation (FMT) for Parkinson's Disease
- OLCIAS
- Jun 22, 2023
- 2 min read
Talk Title: Fecal Microbiota Transplantation (FMT) for Parkinson's Disease
Author: Dr. Sampoornam. W, Professor, Department of Mental Health Nursing, Annai JKK Sampoorani Ammal College of Nursing,
Komarapalayam, India Email ID: drsampoornamwebster@gmail.com Volume: Parkinson's Disease 2023_CN37_AA02 The International Live Conference on Parkinson's Disease Date: July 15, 2023 Time: 8 PM Indian Standard Time Location: Online Conference Theme: The Future of Parkinson's Disease Research and Clinical Practice Abstract: Fecal microbiota transplantation (FMT) is a procedure that involves transferring fecal material from a healthy donor into the gastrointestinal tract of a recipient. The goal of FMT is to restore the balance of gut bacteria and improve the recipient's overall gut health. While FMT has shown promising results in treating certain gastrointestinal conditions, such as Clostridium difficile infection, its use in Parkinson's Disease (PD) is still in the experimental stage, and more research is needed to establish its efficacy and safety. Several studies have suggested a potential link between gut microbiota and Parkinson's disease. It is believed that alterations in the gut microbiome may contribute to the development and progression of PD. The gut-brain axis, a bidirectional communication system between the gut and the brain, plays a role in this connection. Some preliminary studies in animal models of Parkinson's disease have shown that fecal microbiota transplantation from healthy donors can improve motor symptoms, reduce inflammation, and protect against the loss of dopaminergic neurons, which are affected in PD. These findings have generated interest in exploring FMT as a potential therapy for PD in humans. However, the current evidence regarding FMT in Parkinson' disease is limited. Clinical trials are underway to investigate its safety, tolerability, and potential benefits in PD patients. These trials aim to determine the optimal method of FMT delivery, the characteristics of the donor microbiota, and the long-term effects of FMT on Parkinson's symptoms and disease progression. It's important to note that FMT is not without risks. Potential complications include infection transmission, allergic reactions, and adverse reactions to the procedure. Therefore, rigorous research and careful evaluation are necessary before FMT can be considered a standard treatment for Parkinson's disease.
